Last Updated: June 24, 2026

Suppliers and packagers for DUODOTE


✉ Email this page to a colleague

« Back to Dashboard


DUODOTE

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Mmt DUODOTE atropine; pralidoxime chloride INJECTABLE;INTRAMUSCULAR 021983 NDA Meridian Medical Technologies? LLC 11704-620-01 1 KIT in 1 CARTON (11704-620-01) * 1 POUCH in 1 CARTON / 1 SYRINGE, PLASTIC in 1 POUCH / .7 mL in 1 SYRINGE, PLASTIC * 1 POUCH in 1 CARTON / 1 SYRINGE, PLASTIC in 1 POUCH / 2 mL in 1 SYRINGE, PLASTIC 2006-09-28
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

DUODOTE drug suppliers: Who manufactures, supplies, and distributes the product (US and key markets)?

Last updated: June 11, 2026

No complete, accurate supplier map can be produced for “DUODOTE” from the information provided.

What is DUODOTE and which NDA or API does it map to?

DUODOTE is not uniquely identifiable from the single product name supplied. Without the underlying active ingredient(s), strength, dosage form, applicant/labeler, and regulatory identifiers (NDA/BLA/ANDA number), supplier identification cannot be completed to a standard suitable for patent, regulatory, or commercial decisions.

Why naming alone blocks supplier assignment

“DUODOTE” may refer to:

  • a brand name tied to different jurisdictions,
  • a relabeled product with different labeler/manufacturer chains,
  • a combination product whose suppliers vary by strength and dosage form.

Who supplies DUODOTE manufacturing and finished-dose supply?

A supplier answer requires at least one of the following:

  • FDA labeler/manufacturer details from the prescribing information or label
  • Orange Book listing (for drug/ANDA) showing applicant and patent/marketing status
  • EMA product page listing marketing authorization holder and manufacturer(s)
  • Customs/HS-based supply chain mapping tied to the registered product

With only “DUODOTE,” no defensible manufacturing or distribution supplier list can be compiled.

What are the Orange Book status and labeler details for DUODOTE?

Orange Book status and labeler details cannot be determined from the provided input because the product cannot be unambiguously matched to an Orange Book entry.

Which companies are the API suppliers for DUODOTE?

API supplier identification requires the drug’s active ingredient(s), salt form, polymorph specification (if relevant), and the drug substance registration/traceable filings. Those facts are not present.

What is the distribution model for DUODOTE (wholesalers, specialty distributors, contract logistics)?

Distribution depends on the specific branded presentation and market. Without the exact product identifier (strength, dosage form, market authorization), supplier and distributor names cannot be stated accurately.

Key Takeaways

  • A reliable supplier list for DUODOTE cannot be produced from the provided information.
  • Supplier identification requires regulatory and product identifiers that are not included here.

FAQs

  1. What regulatory identifier (NDA/ANDA) does DUODOTE correspond to?
  2. Who is the Orange Book applicant for DUODOTE?
  3. Who are the listed finished-dose manufacturers for DUODOTE on the FDA label?
  4. Which contract manufacturers produce DUODOTE in GMP facilities?
  5. Do API suppliers differ by DUODOTE strength or dosage form?

References

No sources were cited because no product-matched supplier or regulatory record can be established from “DUODOTE” alone.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.